Company page

Contineum Therapeutics, Inc.

Contineum Therapeutics, Inc. (CTNM) is a public company based in America, with a market capitalization of approximately $504.34 million. The company focuses on developing innovative therapeutic solutions. As a publicly traded entity, CTNM is listed on the stock market, providing investors with opportunities to engage with its growth and developments.